Skip to search formSkip to main contentSkip to account menu

Metronomic Chemotherapy

Known as: metronomic therapy 
A chemotherapy regimen consisting of repetitive, low doses of chemotherapy drugs that are designed to minimize toxicity. This therapeutic treatment… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02.
BACKGROUND Metronomics is defined by the combination of metronomic chemotherapy and drug repositioning. Since off-patent… 
2011
2011
High Circulating Endothelial Progenitor Levels Associated with Poor Survival of Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Combined with Metronomic Chemotherapy
Objectives: We examined whether circulating endothelial progenitor (CEP) and circulating endothelial cell (CEC) levels had… 
Review
2010
Review
2010
Antiangiogenic strategies in breast cancer management.
2009
2009
Effective Treatment of Advanced Human Melanoma Metastasis in Immunodeficient Mice Using Combination Metronomic Chemotherapy Regimens
Purpose: The development of effective therapeutic approaches for treatment of metastatic melanoma remains an immense challenge… 
2008
2008
Antiangiogenic Metronomic Chemotherapy
Accessible online at: www.karger.com/onk Fax +49 761 4 52 07 14 E-mail Information@Karger.de www.karger.com Most of the phase I… 
2008
2008
Biologic Markers of Angiogenesis: Circulating Endothelial Cells in Patients with Advanced Malignancies Treated on Phase I Protocol with Metronomic Chemotherapy and Celecoxib
Preclinical studies demonstrate anti-angiogenic activity of low doses of chemotherapy; selective cox-2 inhibitors are also… 
Highly Cited
2006
Highly Cited
2006
High-Dose Celecoxib and Metronomic “Low-dose” Cyclophosphamide Is an Effective and Safe Therapy in Patients with Relapsed and Refractory Aggressive Histology Non–Hodgkin's Lymphoma
Purpose: Angiogenesis is increased in aggressive histology non–Hodgkin's lymphoma and may be a target with selective… 
2006
2006
Design of an implantable active microport system for patient specific drug release
We present a novel concept of an implantable active microport based on micro technology that incorporates a high-resolution… 
2006
2006
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide
A limited repertoire of chemotherapeutics is available for the therapy of metastasizing angiosarcoma. Moreover, response rates… 
Highly Cited
2005
Highly Cited
2005
Interim report of a phase II clinical trial of bevacizumab (Bev) and low dose metronomic oral cyclophosphamide (mCTX) in recurrent ovarian (OC) and primary peritoneal carcinoma: A California Cancer…
5000 Background: Bev is a recombinant humanized anti-VEGF monoclonal antibody that inhibits the growth of a number of human… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)